MiNK Therapeutics, Inc. (INKT)
11.84
+0.39
(+3.41%)
USD |
NASDAQ |
Sep 09, 16:00
11.84
0.00 (0.00%)
After-Hours: 17:47
MiNK Therapeutics Net Income (Quarterly) : -3.128M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.128M |
| March 31, 2026 | -2.742M |
| December 31, 2025 | -2.602M |
| September 30, 2025 | -2.888M |
| June 30, 2025 | -4.238M |
| March 31, 2025 | -2.767M |
| December 31, 2024 | -2.464M |
| September 30, 2024 | -1.807M |
| June 30, 2024 | -2.702M |
| March 31, 2024 | -3.813M |
| December 31, 2023 | -5.459M |
| Date | Value |
|---|---|
| September 30, 2023 | -5.116M |
| June 30, 2023 | -6.197M |
| March 31, 2023 | -5.686M |
| December 31, 2022 | -7.769M |
| September 30, 2022 | -6.332M |
| June 30, 2022 | -6.113M |
| March 31, 2022 | -7.777M |
| December 31, 2021 | -5.765M |
| September 30, 2021 | -14.27M |
| June 30, 2021 | -6.335M |
| March 31, 2021 | -3.846M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.128M |
| EPS Diluted (Quarterly) | -0.6227 |
| Enterprise Value | 49.55M |
| Earnings Yield | -20.25% |
| Normalized Earnings Yield | -20.71 |